Safety, Efficacy of 2 Zika Virus Vaccine Trials Reported – Infectious Disease Advisor
12/27/2017
Infectious Disease AdvisorSafety, Efficacy of 2 Zika Virus Vaccine Trials ReportedInfectious Disease AdvisorTwo DNA vaccines were safe and well tolerated by participants in a phase 1 trial, according to research published in The Lancet, with one vaccine being advanced to phase 2 study. The recent outbreak of Zika virus in the Americas and its associated …Global Zika Virus Market Growth(CAGR) by 2022: Cerus, NewLink Genetics, Sanofi and IntrexonMilTechGlobal Zika Virus Vaccines Market Global Potential Growth, Share, Demand And Analysis Of Key Players- Research …satPRnews (press release)all 5 news articles »
12/27/2017
Infectious Disease AdvisorSafety, Efficacy of 2 Zika Virus Vaccine Trials ReportedInfectious Disease AdvisorTwo DNA vaccines were safe and well tolerated by participants in a phase 1 trial, according to research published in The Lancet, with one vaccine being advanced to phase 2 study. The recent outbreak of Zika virus in the Americas and its associated …Global Zika Virus Market Growth(CAGR) by 2022: Cerus, NewLink Genetics, Sanofi and IntrexonMilTechGlobal Zika Virus Vaccines Market Global Potential Growth, Share, Demand And Analysis Of Key Players- Research …satPRnews (press release)all 5 news articles »